Sign Up to like & get
recommendations!
0
Published in 2021 at "Rheumatology"
DOI: 10.1093/rheumatology/keab252
Abstract: OBJECTIVES Tumor necrosis factor (TNF) receptor-1 associated periodic syndrome (TRAPS) is a rare autosomal dominant autoinflammatory disorder associated with mutations in the TNF receptor super family 1A (TNFRSF1A) gene. AA amyloidosis (AA) is the most…
read more here.
Keywords:
periodic syndrome;
tumor necrosis;
syndrome traps;
receptor ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Journal of Thrombosis and Haemostasis"
DOI: 10.1111/jth.15158
Abstract: Trial of Rivaroxaban in AntiPhospholipid Syndrome was a prospective randomized, open‐label, noninferiority study conducted in 14 centers in Italy. Rivaroxaban was compared with warfarin for the prevention of thromboembolic events, major bleeding, and vascular death…
read more here.
Keywords:
antiphospholipid syndrome;
rivaroxaban;
rivaroxaban antiphospholipid;
syndrome traps ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2017-eular.3485
Abstract: Background Tumor necrosis factor receptor (TNFR)–associated periodic syndrome (TRAPS) is an autosomal-dominant disease caused by gain-of-function mutations in the TNFRSF1A gene, which encodes the 55-kd TNFR type I (TNFRI) protein. Mosaicism has been recently idenitfied…
read more here.
Keywords:
periodic syndrome;
mosaicism;
case;
syndrome traps ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms21093263
Abstract: Tumor necrosis factor receptor-associated periodic syndrome (TRAPS) is an autosomal dominant autoinflammatory syndrome characterized by prolonged and recurrent episodes of fever, abdominal and/or chest pain, arthralgia, myalgia, and erythematous rash. TRAPS is associated with heterozygous…
read more here.
Keywords:
periodic syndrome;
syndrome traps;
receptor;
syndrome ... See more keywords